2 Products
Bi-specific single-domain antibodies represent a groundbreaking advancement in the field of immunotherapy and targeted drug delivery. These innovative…
Select optionsFluoTag®-X2 anti-CD62L is derived from an in-house developed single-domain antibody (sdAb) recognizing the human lymphocyte marker CD62L (L-selectin)…
Select options